Medical > Medical > Emerging Market for Clinical Trials in Brazil


Emerging Market for Clinical Trials in Brazil

Rising Financial and Regulatory Pressures on Western Pharmaceutical Companies Will Continue to Drive the Clinical Trial Market Growth in Brazil
London, London, United Kingdom ( 6/23/2011 12:00:00 AM - Rising Financial and Regulatory Pressures on Western Pharmaceutical Companies Will Continue to Drive the Clinical Trial Market Growth in Brazil

The pharmaceutical industries of the US and Europe have been facing severe financial constraints
over the past few years, which are expected to worsen in the coming years. With constraints such
as the increasing cost of introducing New Molecular Entities (NME), which is expected to reach
more than $3 billion in 2008, tightening regulatory pressures resulting in fewer FDA and other
regulatory agency approvals, blockbuster drugs worth more than $100 billion experiencing patent
expiry by 2014, and the drying developmental pipelines of the pharmaceutical industry, cost cutting
pressures are mounting on pharmaceutical companies, especially the big ones. These pressures
are expected to drive these companies towards low-cost countries such as Brazil for their R&D
activities, which are one of their major expenses.

Brazil, over the last decade, has developed significant capabilities in clinical trials. Brazil is able to
provide significant cost savings in the range of 20-30% for clinical trials. With discovery research
occupying close to one-third of the Research and Development (R&D) expenditure for the Western
pharmaceutical industry, outsourcing to low-cost countries is logical. As the financial and regulatory
pressures grow on the US and European pharmaceutical industry, it is expected to further propel
the growth in the clinical trial market in Brazil.

For Sample Pages, please click or add the below link to your browser:

Patient recruitment causes clinical trials to delay in Western countries as people have access to
good medical care from government hospitals and also they have medical insurance by which they
can afford treatment even in private hospitals. But in Brazil many people are devoid of medical care
as there are limited facilities concentrated to a few cities/provinces making these patients can
easily available for conducting clinical trials and also it’s easier to find patients who are currently not
on any therapy. Brazil has the large treatment naïve population concentrated in urban area,
compared to the US, the UK, Western Europe and other countries of Latin America.

GBI Research, the leading business intelligence provider, has released its latest report, “Emerging
Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are
Shortening the Regulatory Approval Process and Advancing the Market” that provides key
data, information and analysis of the major trends and issues affecting the clinical trial market in
Brazil. The report provides comprehensive insight on the reasons for outsourcing clinical trials to
Brazil and the key services provided by the Clinical Research Organizations (CROs) of Brazil. The
report provides a detailed analysis of the Brazilian market in terms of its size, and the major service
offerings of the CROs in Brazil. The report also discusses the factors that are driving the clinical
trial market in Brazil. The report delves into the key documents required by the investigator and the
sponsor before, during and after the conduct of clinical trials. The report also provides key alliances
between the CROs of other countries and the local CROs of Brazil. The report also looks into the
major challenges that can restrict the growth of the clinical trials market in Brazil.

For further details, please click or add the below link to your browser:

Visit our report store:
For more details contact:

North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782

About GBI Research

GBI Research is a global market intelligence services company providing information research and analysis products and services.
Category : Medical : Medical
Subscribe to Medical Press Releases

Keywords : Clinical Trials in Brazil , Medical Devices
Add a comment     Bookmark and Share     Print this News    Email it

Contact Information

Rajesh Gunnam

GBI Research
John Carpenter House, John Carpenter Street
London, London, EC4Y 0AN
United Kingdom

Visit Our Site

Press Release Distribution Service $21
Press Release Distribution Service

Get your Press release distributed to 90+ PR directories and 100’s of Journalists. FREE featured news at PRBD.NET, and worth $27.

Post New Comment
* Your Name:  
* Email:  
* Comment:  

Potent Male Enhancement Supplement ‘SuperXten’ Now Available With 67 Day Money Back Guarantee
By : Syl vester | 08-22-2012 | Healthcare | Total Views:34164
Are you unable to get and maintain an erection? SuperXten’s active ingredients not just increases sexual desire but stamina and sexual performance too

Enjoy Greater Sex Drive with Hormone Therapy
By : Brian Tully | 04-27-2012 | Healthcare | Total Views:18821
Hormone therapy is one of the easiest ways to boost the levels of hormone and increase sex drive in older men.

VoiceAmerica Kids Broadcast Live at Microsoft for Windows 8 Release
By : Jeff Gerstl | 11-09-2012 | Technology | Total Views:17857
Internet broadcasting pioneer, producing and syndicating online audio and video, is pleased to announce that two talk-radio shows for the VoiceAmerica Kids channel

Online scrap trading website launched online live chat for its members.
By : Guna Nadar | 08-24-2009 | Corporations | Total Views:15086
“The leading revolutionary feature for a better personal and professional communication”

For free Registry cleaner get in touch with right away
By : Matthew M. Wiseman | 03-26-2012 | Business | Total Views:12204
The exceptional website offers free registry cleaner that will clean your PC errors and give your system optimal performance